Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | +86-18752526868 |
| E-mail: | jennysun@yzqyyykj.com |
| QQ: | 1035253726 |
| Skype: | Chat Now! |
| Address: | No.168 Zhicheng Road Industrial District Maji Town Yizheng City Jiangsu Province China |
|
Yangzhou Qinyuan Pharmatech Co.,ltd was founded in the wonderful city Yangzhou, Jiangsu province in 2015 which area is 35000 square meter. QINYUAN has standard workshops, specialized laboratories, excellent R&D team, skilled workers, talented and careful quality inspectors for supporting our annual production capacity 50tons,
We attended on CPHI exhibition every year. Customers are very interested in our products for communicating more in details at booth. Our profession helps us get customers full trust and support.
The main products are the Active Pharmaceutical Ingredients and their intermediates, organic compounds, chemical reagents, pharmaceutical raw materials, medicine intermediates, natural chemical drugs etc. We have the ability to support all products’ technology guidance and customized design.
Our R&D team is very excellent, they are skilled and very careful for all experiments. They have worked in this area for 20years. Any your requirements, we could meet. For each order, we put COA paper remarked all data clear. Customers’ satisfy, our long-term pursue.
We have 80 workers who passed skilled train. They always pay full attention to every procedure of production in order to make sure all goods are good.
The QA members keep energetic mind and concentrate on inspection from original raw materials to finished goods all the time.
All of QINYUAN members believe “Quality First, Customers First, Integrity-based’ marketing idea of services, for the majority of our customers old and new service.
Any purchasing order plan or inquiry, welcome to contact with me. Always our pleasure to hear from you and support you.
Welcome dear all to visit us.
Thanks very much for your cooperation.
|
|
| Product Name | MF | CAS | Details |
|---|
| 4-Chloropyridine-2- forMic acidMethyl ester | C7H6ClNO2 | 24484-93-3 | Details |
| 3-Amino-4-methylbenzoic acid ethyl ester | C10H13NO2 | 41191-92-8 | Details |
| 3-Amino-5-bromobenzotrifluoride | C7H5BrF3N | 54962-75-3 | Details |
| lenvatinib | C21H19ClN4O4 | 417716-92-8 | Details |
| (R)-(+)-1-(1-Naphthyl)ethylamine | C12H13N | 3886-70-2 | Details |
| 2,3-dimethyl-6-nitro-1H-indazole | C9H9N3O2 | 444731-73-1 | Details |
| Nintedanib Ethanesulfonate Salt | C33H39N5O7S | 656247-18-6 | Details |
| 4'-chloro-5,5-diMethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carbaldehyde | C15H17ClO | 1228837-05-5 | Details |
| 3-nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzenesulfonaMide | C12H17N3O5S | 1228779-96-1 | Details |
| methyl 2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-4-fluorobenzoate | C15H11FN2O3 | 1235865-75-4 | Details |
| 3-Methyl-6-nitro-1H-indazole | C8H7N3O2 | 6494-19-5 | Details |
| 1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one | C10H12N2O | 55314-16-4 | Details |
| 4-(4-Aminophenoxy)-N-methylpicolinamide | C13H13N3O2 | 284462-37-9 | Details |
| Regorafenibhydrate | C21H17ClF4N4O4 | 1019206-88-2 | Details |
| 2-Ethyl-5-nitrobenzenamine | C8H10N2O2 | 20191-74-6 | Details |
| Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
| 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine dihydrochloride | C19H28Cl2N2 | 1628047-87-9 | Details |
| 2-(2-Fluoro-4-iodoanilino)-3,4-difluorobenzoic Acid | C13H7F3INO2 | 391211-97-5 | Details |
| 4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol | C15H11ClFN3O2 | 184475-71-6 | Details |
| 2-Amino-6-fluorobenzonitrile | C11H16N4O2 | 23491-48-7 | Details |
| lenvatinib Mesylate | C22H23ClN4O7S | 857890-39-2 | Details |
| Methyl 3-amino-4-methylbenzoate | C9H11NO2 | 18595-18-1 | Details |
| (S)-(-)-1-(1-Naphthyl)ethylamine | C12H13N | 10420-89-0 | Details |
| Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
| 1-bromo-3-nitro-5-(trifluoromethyl)- | C7H3BrF3NO2 | 630125-49-4 | Details |
| 3-(3-Trifluoromethylphenyl)propionicacid | C10H9F3O2 | 585-50-2 | Details |
| dasatinibmonohydrate | C22H28ClN7O3S | 863127-77-9 | Details |
| Regorafenib (Hydrochloride) | C21H16Cl2F4N4O3 | 835621-07-3 | Details |
| Cinacalcet | C22H22F3N | 226256-56-0 | Details |
| Abemaciclib | C27H32F2N8 | 1231929-97-7 | Details |
| N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMine | C14H14ClN5 | 444731-75-3 | Details |
| N-(2-chloropyriMidin-4-yl)-2,3-diMethyl-2H- indazol-6-aMine | C13H12ClN5 | 444731-74-2 | Details |
| Benzenesulfonamide,5-amino-2-methyl- | C7H10N2O2S | 6973-09-7 | Details |
| Nilotinib hydrochloride monohydrate | C28H25ClF3N7O2 | 923288-90-8 | Details |
| Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
| Pazopanib hydrochloride | C21H24ClN7O2S | 635702-64-6 | Details |
| 2,3-dimethyl-2H-indazol-6-amine hydrochloride | C9H12ClN3 | 635702-60-2 | Details |
| 5-Thiazolecarboxamide,N-(2-chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]- | C16H13Cl2N5OS | 302964-08-5 | Details |
| 4-(4-Amino-3-fluorophenoxy)pyridine-2-carboxylic acid methylamine | C13H12FN3O2 | 757251-39-1 | Details |
| (R)-(+)-1-(1-Naphthyl)ethylamine hydrochloride | C12H14ClN | 82572-04-1 | Details |
| Nilotinib | C28H22F3N7O | 641571-10-0 | Details |
| 5-Thiazolecarboxamide,2-amino-N-(2-chloro-6-methylphenyl)- | C11H10ClN3OS | 302964-24-5 | Details |
| 2-Methyl-5-nitrobenzenesulfonamide | C7H8N2O4S | 6269-91-6 | Details |
| N-Methyl-4-chloropyridine-2-carboxamide | C7H7ClN2O | 220000-87-3 | Details |
| 2,4-Dichloropyrimidine | C4H2Cl2N2 | 3934-20-1 | Details |
| ABT-199 | C45H50ClN7O7S | 1257044-40-8 | Details |
| CinacalcetHydrochloride | C22H23ClF3N | 364782-34-3 | Details |
| 3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate | C11H16N4O5 | 641569-96-2 | Details |
| (2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one | C10H12N2O | 123367-26-0 | Details |
| 4-Amino-3-fluorophenol | C6H6FNO | 399-95-1 | Details |
| Gefitinib | C22H24ClFN4O3 | 184475-35-2 | Details |
| 1H-Pyrrolo[2,3-b]pyridin-5-ol, 1-[tris(1-methylethyl)silyl]- | C16H26N2OSi | 685514-01-6 | Details |
| N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide | C22H20F3NO | 1005450-55-4 | Details |
| 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine | C19H27ClN2 | 1228780-72-0 | Details |
| 2-[(1H-Pyrrolo[2,3-b]pyridin-5-yl)oxy]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazin-1-yl]benzoic acid | C33H35ClN4O3 | 1235865-77-6 | Details |
| 3-[3-(Trifluoromethyl)phenyl]prop-2-enoic acid | C10H7F3O2 | 779-89-5 | Details |
| Pazopanib | C21H23N7O2S | 444731-52-6 | Details |
| Sorafenib tosylate | C21H16ClF3N4O3.C7H8O3S | 475207-59-1 | Details |
| Nintedanib | C31H33N5O4 | 928326-83-4 | Details |
| Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, ethyl ester | C19H18N4O2 | 641569-97-3 | Details |
| 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole | C11H12BrFN2 | 1231930-33-8 | Details |
| Sorafenib | C21H16ClF3N4O3 | 284461-73-0 | Details |
| 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | C17H14N4O2 | 641569-94-0 | Details |
| 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | C11H10F3N3 | 641571-11-1 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||